Common variants at 19p13 are associated with susceptibility to ovarian cancer

Authors:
  • TGthe Australian Ovarian Cancer Study Group
    the Australian Ovarian Cancer Study Group
  • TCthe Australian Cancer Study (Ovarian Cancer)
    the Australian Cancer Study (Ovarian Cancer)
  • OCon behalf of the Ovarian Cancer Association Consortium
    on behalf of the Ovarian Cancer Association Consortium

Abstract
Paul Pharoah and colleagues report a genome-wide association study for survival time after diagnosis of epithelial ovarian cancer and a parallel analysis of susceptibility to epithelial ovarian cancer. They identified two SNPs at 19p13.11 that associated with susceptibility to the serous subtype of epithelial ovarian cancer. Epithelial ovarian cancer (EOC) is the leading cause of death from gynecological malignancy in the developed world, accounting for 4% of the deaths from cancer in women1. We performed a three-phase genome-wide association study of EOC survival in 8,951 individuals with EOC (cases) with available survival time data and a parallel association analysis of EOC susceptibility. Two SNPs at 19p13.11, rs8170 and rs2363956, showed evidence of association with survival (overall P = 5 × 10−4 and P = 6 × 10−4, respectively), but they did not replicate in phase 3. However, the same two SNPs demonstrated genome-wide significance for risk of serous EOC (P = 3 × 10−9 and P = 4 × 10−11, respectively). Expression analysis of candidate genes at this locus in ovarian tumors supported a role for the BRCA1-interacting gene C19orf62, also known as MERIT40, which contains rs8170, in EOC development.

This publication has 21 references indexed in Scilit: